Secondary HIV Prevention and Adherence Among HIV-infected Drug Users
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01741311|
Recruitment Status : Active, not recruiting
First Posted : December 4, 2012
Last Update Posted : July 2, 2018
University of Connecticut
National Institute on Drug Abuse (NIDA)
APT Foundation, Inc.
Information provided by (Responsible Party):
Michael Copenhaver, University of Connecticut
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Active, not recruiting|
|Estimated Primary Completion Date :||June 2018|
|Estimated Study Completion Date :||June 2018|
Avants SK, Margolin A, Usubiaga MH, Doebrick C. Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy. J Subst Abuse Treat. 2004 Mar;26(2):67-78.